Bilateral internal mammary artery grafting for coronary artery bypass grafting: Why men versus women?

Annals of Thoracic Surgery

Volumn 74, Issue 5, 2002, Pages 1435-1437

  Rahimtoola, Shahbudin H ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; EDITORIAL; FEMALE; FOLLOW UP; GENDER; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; SAPHENOUS VEIN; SURVIVAL RATE; TREATMENT OUTCOME;

ACTUARIAL ANALYSIS; AGED; AGED, 80 AND OVER; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERNAL MAMMARY-CORONARY ARTERY ANASTOMOSIS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; REOPERATION; RETROSPECTIVE STUDIES; SEX FACTORS; SURVIVAL RATE;

EID: 0036841427     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(02)04068-7     Document Type: Editorial

References (15)

1. Kurlansky PA, Traad EA, Galbut DL, Singer S, Zucker M, Ebra G. Coronary bypass surgery in women: A long-term comparative study of quality of life following bilateral internal mammary artery grafting in men and women. Ann Thorac Surg 2002;74:1517-25.
2. Rahimtoola SH, Grunkemeier GL, Starr A. Ten-year survival after coronary artery bypass surgery for angina in patients aged 65 years and older. Circulation 1986;74(3):509-17.
3. Rahimtoola SH. Coronary bypass surgery for chronic angina-1981: A perspective. Circulation 1982;65(2):226-41.
4. Cavender JB, Rogers WJ, Fisher LD, Gersh BJ, Coggin CJ, Myers WO. Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the Coronary Artery Surgery Study (CASS): 10-Year follow-up. J Am Coll Cardiol 1992;20:287-94.
5. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
6. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333:1301-7.
7. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001-9.
8. LIPID Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998;339:1349-57.
9. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAP/Tex CAPS. JAMA 1998;279:1615-22.
10. The Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J Med 1997;336:153-62.
11. Knatterud GL, Rosenberg Y, Campeau L, et al. Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose antico-agulation in the Post Coronary Artery Bypass Graft Trial. Circulation 2000;102:157-65.
12. Fonarow GC, French WJ, Parsons LS, Sun H, Malmgren JA. Use of lipid-lowering medications at discharge in patients with acute myocardial infarction. Data from the National Registry of Myocardial Infarction 3. Circulation 2001;103:38-44.
13. Dobson R. Doctors put women at back of heart bypass queue. The Sunday Times of United Kingdom May 12, 2002, p. 1.7.
14. Rahimtoola SH, Bennett AJ, Grunkemeier GL, Block P, Starr A. Survival at 15 to 18 years after coronary bypass surgery for angina in women. Circulation 1993;88(Part 2):71-8.
15. Rahimtoola SH, Fessler CL, Grunkemeier GL, Starr A. Survival 15 to 20 years after coronary bypass surgery for angina. J Am Coll Cardiol 1993;21:151-7.